Publication

Article

CURE

Summer 2014
Volume13
Issue 2

Group Launches Global Initiative to Support Cancer Research

Author(s):

Katherine Lagomarsino

Project: EveryChild is collecting biologic samples, such as blood, tissue and other specimens, from children undergoing treatment.

The world's largest organization dedicated to childhood and adolescent cancer research is engaging more than 200 pediatric cancer programs around the U.S. to participate in collecting biologic samples, such as blood, tissue and other specimens, from children undergoing treatment. Called Project:EveryChild, the purpose of the Children’s Oncology Group (COG) initiative is to develop new treatments for childhood cancers that are both common and rare, including leukemias, lymphomas, solid tumors and tumors of the central nervous system. The information gleaned from these biospecimens will be entered in a secure database that can be accessed by researchers worldwide with the hope they can utilize it to discover more effective and less toxic treatment options, as well as cures.

Articles in this issue
New Guidelines Recommend Genetic Testing for Lynch Syndrome
National Women's Survivors Convention
Ruling Grants Patients Direct Access to Lab Results
A Spice for Life
Group Launches Global Initiative to Support Cancer Research
Chemo Brain Doc Notes App
Survivorship Issues Can't Be Ignored
Husband's Guide to Breast Cancer: A Complete & Concise Plan for Every Stage
Bone Basics
Assessing the Risk
Finding the Positives in Negative Results
Support for Chemotherapy-Induced Peripheral Neuropathy
Avoid Carcinogens, Not the Grill This Summer
Transitioning Care: A Caregiver's Role
The High Cost of Hospital Readmissions
Related Videos
Image of a man wearing a black suit and tie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with a brown hair tied into a bun.
Image of Dr. Jorge Cortes; a man with short dark hair wearing a suit.
Image of a man with brown hair.
Image of a woman with short brown hair and glasses.
Image of a woman with short brown hair and glasses.
Image of a man with brown hair and a suit and tie.
Image of a woman with brown bobbed hair with glasses.
Related Content
Illustration of kidneys.
November 20th 2024

PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy

Gina Mauro
PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels were linked to worse outcomes.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of woman with brown hair.
November 19th 2024

Newer Therapies for Acute Lymphoblastic Leukemia May Reduce Side Effects

Spencer Feldman Darlene Dobkowski, MA
New treatments for acute lymphoblastic leukemia may lead to fewer side effects than chemotherapy, as they target cancer cells more precisely, an expert said.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
"FDA" text.
November 15th 2024

FDA Approves Revuforj for Relapsed/Refractory Acute Leukemia Subset

Darlene Dobkowski, MA
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.
Illustration of blood.
November 15th 2024

FDA Approves Danziten for Leukemia Subset That Does Not Require Fasting

Darlene Dobkowski, MA
Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive chronic myeloid leukemia.